Fludarabine-containing regimens severely impair peripheral blood stem cells mobilization and collection in acute myeloid leukaemia patients

British Journal of Haematology

Volumn 105, Issue 3, 1999, Pages 775-779

  Visani, Giuseppe ^a,b   Lemoli, R M ^a   Tosi, P ^a   Martinelli, G ^a   Testoni, N ^a   Ricci, P ^a   Piccaluga, P P ^a   Pastano, R ^a   Leopardi, G ^a   Dizdari, A ^a   Motta, M R ^a   Rizzi, S ^a   Tura, S ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Autologous transplantation; Fludarabine; Myeloid leukaemia; Stem cells

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; MESNA; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKAPHERESIS; LEUKEMIA REMISSION; MALE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIGENS, CD34; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; VIDARABINE;

EID: 0033002175     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01379.x     Document Type: Article

References (27)

1. Bennett, J.M., Catovsky, D.M. & Daniel, M.T. (1977) Proposals for the classification of acute leukaemias. British Journal of Haematology. 33, 451-458.
2. Burnett, A.K., Goldstone, A.H. & Stevens, R.M.F. (1998) Randomized comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. Lancet, 351, 700-709.
3. Cheson, B.D., Cassileth, P.A. & Head, D.R. (1990) Report of National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. Journal of Clinical Oncology, 8, 813-819.
4. Clavio, M., Carrara, P., Miglino, M. & Gobbi, M. (1996) High efficacy of fludarabine containing therapy (FLAG-FLANG) in poor risk acute myeloid leukaemia. Haematologica, 81, 513-520.
5. Demirer, T., Petersen, F.B. & Bensinger, W.I. (1996) Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia. Bone Marrow Transplantation, 18, 29-34.
6. Estey, E., Thall, P. & Andreeff, M. (1994) Use of granulocyte colony-stimulating factor before,during and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor. Journal of Clinical Oncology, 12, 671-678.
7. Gorin, N.C., Dicke, K. & Lowenberg, B. (1995) High dose therapy for acute myelocytic leukemia; treatment strategy: what is the choice? Annals of Oncology. 4, (Suppl.1), 59-80.
8. Johnson, S. & Smith, A.G. for the French Cooperative Group on CLL (1996) Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for advanced-stage chronic lymphocytic leukaemia. Lancet, 347, 1432-1438.
9. Korbling, M., Fliedner, T.M., Holle, R. & Magrin, S. (1991) Autologous blood stem cell (ABSCT) versus purged bone marrow transplantation (pABMT) in standard risk AMI: influence of source and cell composition of the autograft on hemopoietic reconstitution and disease free survival. Bone Marrow Transplantation, 7, 343-349.
10. Laporte, J.P., Gorin, N.C. & Feuchtenbaum, J. (1997) Relapse after autografting with peripheral blood stem cells. Lancet, ii, 1993.
11. + cells to remove circulating tumor cells. Blood, 87, 1625-1634.
12. Lemoli, R.M., Visani, G., Leopardi, G., Motta, M.R., Rizzi, S., Testoni, N., Curti, A. & Tura, S. (1999) Autologous transplantation of chemotherapy-purged PBSC collection from high-risk leukemia patients: a pilot study. Bone Marrow Transplantation, in press.
13. Lowenberg, B., Verdonck, L.J. & Dekker, N. (1997) Autologous bone marrow transplantation in acute myeloid leukemia in first remission: results of a Dutch prospective study. Journal of Clinical Oncology, 8, 287-294.
14. Martin, C., Torres, A. & Leon, A. (1998) Autologous peripheral blood stem cell transplantation mobilized with G-CSF in AML in first complete remission: role of intensification therapy in outcome. Bone Marrow Transplantation, 21, 375-382.
15. Mehta, J., Powles, R. & Singhal, S. (1995) Peripheral blood stem cell transplantation may result in increased relapse of acute myeloid leukemia due to reinfusion of a higher number of malignant cells. Bone Marrow Transplantation, 15, 652-653.
16. Miggiano, M.C., Gherlinzoni, F., Rosti, G. & Visani, G. (1996) Autologous bone marrow transplantation in late first complete remission improves outcome in acute myelogenous leukemia. Leukemia, 10, 402-409.
17. Montillo, M., Tedeschi, A. & Leoni, P. (1994) Recurrence of autoimmune thrombocytopenia after treatment with fludarabine in a patient with chronic lymphocytic leukemia. Leukemia and Lymphoma, 15, 187-188.
18. Motta, R.M., Mangianti, S., Rizzi, S., Ratta, M., Campanini, E., Fortuna, A., Fogli, M., Tura, S. & Lemoli, R.M. (1997) Pharmacological purging of minimal residual disease from peripheral blood stem cell collections of acute myeloblastic leukemia patients: preclinical studies. Experimental Hematology, 25, 1261-1269.
19. Reiffers, J., Korbling, M. & Labopin, M. (1992) Autologous blood stem cell transplantation versus autologous bone marrow transplantation for acute myeloid leukemia in first complete remission. International Journal of Cell Cloning, 7, (Suppl.1), 111-113.
20. Sanz, M.A., de la Rubia, J. & Sanz, G. (1993) Busulphan and cyclophosphamide followed by complete remission: a report from a single institution. Journal of Clinical Oncology, 11, 1661-1667.
21. Schiller, G., Lee, M. & Miller, T. (1997) Transplantation of autologous peripheral blood progenitor cells procured after high dose cytarabine based consolidation chemotherapy for adults with acute myelogenous leukemia in first remission. Leukemia, 11, 1533-1539.
22. Schlenk, R.F., Dohner, H. & Pforsich, M. (1997) Successful collection of peripheral blood progenitor cells in patients with acute myeloid leukaemia following early consolidation therapy with granulocyte colony-stimulating factor-supported high-dose cytarabine and mitoxantrone. British Journal of Haematology, 99, 386-393.
23. Sorensen, J.M., Vena, DA. & Fallavolita, A. (1997) Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the Group C protocol mechanism of the National Cancer Institute: five-year follow-up report. Journal of Clinical Oncology, 15, 458-465.
24. Testoni, N., Lemoli, R.M., Martinelli, G., Carboni, C., Pelliconi, S., Ottaviani, E., Ruggeri, D., Rizzi, S., Motta, M.R., Visani, G. & Tura, S. (1998) Autologous PBSCT in acute myeloblastic leukemia and MDS: evaluation of tumor cell contamination of leukaphereses by cytogenetic and molecular methods. Bone Marrow Transplantation, 22, 1065-1070.
25. To, L.B., Roberts, M.M. & Haylock, D.N. (1992) Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants,autologous bone marrow transplants and allogeneic bone marrow transplants. Bone Marrow Transplantation, 9, 277-284.
26. Visani, G., Di Nota, A. & Tosi, P. (1990) Cryopreserved autologous bone marrow transplantation in patients with acute nonlymphoid leukemia: chemotherapy before harvesting is the main factor in delaying the hematological recovery. Cryobiology, 27, 103-106.
27. Visani, G., Tosi, P. & Zinzani, P.L. (1994) FLAG (fludarabine + high dose ara-C + G-CSF): an effective and tolerable protocol for the treatment of 'poor risk' acute myeloid leukemias. Leukemia, 8, 1842-1846.